Live Breaking News & Updates on ஜோசபின் லோப்ஸ் கார்டோசோ

Stay updated with breaking news from ஜோசபின் லோப்ஸ் கார்டோசோ. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

More Support for Gene Assay to Guide Breast Cancer Treatment

email article
Patients with ultralow-risk breast cancer according to genomic assessment had excellent long-term outcomes regardless of clinical risk or whether they received adjuvant therapy, a new analysis of a randomized trial showed.
The 8-year breast cancer-specific survival (BCSS) was 99.2% among patients classified as clinically high-risk but ultralow-risk by the MammaPrint 70-gene assay. Patients with an ultralow-risk genomic assessment and low clinical risk had an 8-year BCSS of 99.7%. Freedom from distant metastasis at 8 years was 97.6% in patients who were clinically and genomically low-risk versus 95.0% for those who were clinically high-risk but genomically low-risk.
In patients with an ultralow-risk genomic assessment, the 8-year distant metastasis-free interval (DMFI) rate was 97.8% with no adjuvant systemic therapy. That compared with an 8-year DMFI of 97.4% in patients who received only adjuvant endocrine therapy and 94.9% in patients who received ....

United States , Noord Holland , Priya Rastogi , Charles Bankhead , Josephine Lopes Cardozo , National Surgical Adjuvant Breast , American Society Of Clinical Oncology , University Of Pittsburgh , Netherlands Cancer Institute , American Society , Clinical Oncology , Surgical Adjuvant Breast , Bowel Project , Medpage Today , Endocrine Therapy , Breast Cancer , ஒன்றுபட்டது மாநிலங்களில் , நூற்த் ஹாலண்ட் , பிரியா ரஸ்டோகி , சார்லஸ் வங்கித் தலை , ஜோசபின் லோப்ஸ் கார்டோசோ , அமெரிக்கன் சமூகம் ஆஃப் மருத்துவ புற்றுநோயியல் , பல்கலைக்கழகம் ஆஃப் பிட்ஸ்பர்க் , நெதர்லாந்து புற்றுநோய் நிறுவனம் , அமெரிக்கன் சமூகம் , மருத்துவ புற்றுநோயியல் ,

Analysis of MINDACT Study Confirms MammaPrint Accurately Identifies Extremely Indolent Ultra Low Risk Breast Cancers

Agendia, Inc., a world leader in precision oncology for breast cancer, today announced that data from the landmark MINDACT study will be shared at the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting in an oral presentation. ....

United States , Noord Holland , William Audeh , Lopes Cardozo , Josephine Lopes Cardozo , Terri Clevenger , European Organization For Research , Agendia Inc , American Society Of Clinical Oncology , Netherlands Cancer Institute , Clinical Oncology , Annual Meeting , Mammaprint Low Risk , Ultra Low Risk , Phd Candidate , Ultralow Risk , Ultra Low , European Organization , Mammaprint Ultra Low , Low Risk , Mammaprint Ultra Low Risk , Chief Medical Officer , Media Contact , Breast Cancer , American Society Of Clinical Oncology , Josephine Lopes Cardozo ,

Agendia, Inc.: Analysis of MINDACT Study Confirms MammaPrint Accurately Identifies Extremely Indolent Ultra Low Risk Breast Cancers

Oral presentation at ASCO 2021 highlights long term data with higher than 99% 8-year breast cancer specific survival for patients with MammaPrint Ultra Low Risk status regardless of clinical risk ....

United States , William Audeh , Lopes Cardozo , Josephine Lopes Cardozo , Terri Clevenger , European Organization For Research , Agendia Inc , American Society Of Clinical Oncology , Netherlands Cancer Institute , Mammaprint Ultra Low Risk , Clinical Oncology , Annual Meeting , Mammaprint Low Risk , Ultra Low Risk , Phd Candidate , Ultralow Risk , Ultra Low , European Organization , Mammaprint Ultra Low , Low Risk , Chief Medical Officer , ஒன்றுபட்டது மாநிலங்களில் , லோப்ஸ் கார்டோசோ , ஜோசபின் லோப்ஸ் கார்டோசோ , டெர்ரி கிளெவெஞ்சர் , ஐரோப்பிய ஆர்கநைஸேஶந் க்கு ஆராய்ச்சி ,

Agendia, Inc.: Analyse der MINDACT-Studie bestätigt, dass MammaPrint extrem indolente Ultra-Low-Risk-Brustkarzinome genau identifiziert

Agendia, Inc.: Analyse der MINDACT-Studie bestätigt, dass MammaPrint extrem indolente Ultra-Low-Risk-Brustkarzinome genau identifiziert
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United States , Lopes Cardozo , Josephine Lopes Cardozo , Terri Clevenger , European Organization For Research , American Society Of Clinical , Netherlands Cancer Institute , Companies In The Field , Data From , American Society , The European Organization , Mammaprint Low Risk Ergebnis , Their Results , These Data Have , Amidst The Final , Chief Medical , About Agendia , Doctors Information , Molecular Subtypisierungstest , Together And Provide , Further Information , Will Find , Original Text , Worldcom Image , Icr Healthcare , ஒன்றுபட்டது மாநிலங்களில் ,